Le lymphome de Hodgkin : stratégies thérapeutiques actuelles et futures-Reference-Cited by-同舟云学术

Le lymphome de Hodgkin : stratégies thérapeutiques actuelles et futures

Published:2018-01 Issue:1 Volume:105 Page:81-98
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Turpin Anthony,Michot Jean-Marie,Kempf Emmanuelle,Mazeron Renaud,Dartigues Peggy,Terroir Marie,Boros Angela,Bonnetier Serge,Castilla-Llorente Cristina,Coman Tereza,Danu Alina,Ghez David,Pilorge Sylvain,Arfi-Rouche Julia,Dercle Laurent,Soria Jean-Charles,Carde Patrice,Ribrag Vincent,Fermé Christophe,Lazarovici Julien

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference98 articles.

1. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications;Campo;Blood,2011

2. null: on some morbid appearances of the absorbent glands and spleen;Hodgkin;Med Chir Trans,1832

3. Estimation nationale de l’incidence des cancers en France entre 1980 et 2012. Partie 2 – Hémopathies malignes;Monnereau,2013

4. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease;Mack;N Engl J Med,1995

5. Familial aggregation of Hodgkin lymphoma and related tumors;Goldin;Cancer,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage activation syndrome revealing Hodgkin's lymphoma: a case report;Pan African Medical Journal;2021

2. Prolonged Remission by Pembrolizumab and Brentuximab-Vedotin Combination Therapy in Heavily-Pretreated Relapsed/Refractory Hodgkin’s Lymphoma;Journal of Hematology;2020

3. Machine learning defined diagnostic criteria for differentiating pituitary metastasis from autoimmune hypophysitis in patients undergoing immune checkpoint blockade therapy;European Journal of Cancer;2019-09

4. Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1;European Journal of Cancer;2018-06